Cargando…
Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is characterized by germline mutations of the FH gene that encodes for the TCA cycle enzyme, fumarate hydratase. HLRCC patients are at risk for the development of an aggressive form of type 2 papillary renal cell carcinoma. By studying the m...
Autores principales: | Sourbier, Carole, Ricketts, Christopher J., Liao, Pei-Jyun, Matsumoto, Shingo, Wei, Darmood, Lang, Martin, Railkar, Reema, Yang, Youfeng, Wei, Ming-Hui, Agarwal, Piyush, Krishna, Murali, Mitchell, James B., Trepel, Jane B., Neckers, Len, Linehan, W. Marston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895110/ https://www.ncbi.nlm.nih.gov/pubmed/31804603 http://dx.doi.org/10.1038/s41598-019-55003-2 |
Ejemplares similares
-
HIF and fumarate hydratase in renal cancer
por: Sudarshan, S, et al.
Publicado: (2007) -
Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma
por: Yang, Youfeng, et al.
Publicado: (2013) -
Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers
por: Sourbier, Carole, et al.
Publicado: (2018) -
Fumarate hydratase-deficient renal cell carcinoma cells respond to asparagine by activation of the unfolded protein response and stimulation of the hexosamine biosynthetic pathway
por: Panarsky, Rony, et al.
Publicado: (2020) -
Structural basis of fumarate hydratase deficiency
por: Picaud, Sarah, et al.
Publicado: (2011)